CRT 2026
Valve and Structural
Maurice Buchbinder, MD, FSCAI
Medical Director
Foundation for Cardiovascular Medicine
San Diego, California, United States
Disclosure information not submitted.
Thomas E. MacGillivray, MD
Physician Executive Director and Chair, Cardiac Surgery
MedStar Health, MedStar Washington Hospital Center
Washington, District of Columbia, United States
Disclosure information not submitted.
Michael J. Reardon, MD
Professor and Allison Family Distinguished Chair of Cardiovascular Research
Houston Methodist DeBakey Heart & Vascular Center
Houston, Texas, United States
Disclosure(s): BSCI: Consulting Fees (e.g., advisory boards) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); High Life: Consulting Fees (e.g., advisory boards) (Ongoing); JValve: Consulting Fees (e.g., advisory boards) (Ongoing); Medtronic: Consulting Fees (e.g., advisory boards) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Siemens: Consulting Fees (e.g., advisory boards) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); WL Gore & Associates: Consulting Fees (e.g., advisory boards) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)
Scott M. Chadderdon, MD
Associate Professor
OHSU
PORTLAND, Oregon, United States
Disclosure(s): Edwards Lifesciences LLC: Consulting Fees (e.g., advisory boards) (Ongoing); Medtronic Inc: Consulting Fees (e.g., advisory boards) (Ongoing)
Sachin S. Goel, MD, FACC, FSCAI
Medical Director, Structural Heart Interventions
Houston Methodist DeBakey Heart & Vascular Center
Houston, Texas, United States
Disclosure information not submitted.
Howard C. Herrmann, MD, FACC, MSCAI
John Bryfogle Professor of Cardiovascular Medicine, Emeritus
Perelman School of Medicine at the University of Pennsylvania
Philadelphia, Pennsylvania, United States
Disclosure(s): Affluent Medical: Consulting Fees (e.g., advisory boards) (Ongoing), Stock Options [in privately held companies] (Ongoing); Artedrone: Consulting Fees (e.g., advisory boards) (Ongoing), Stock Options [in privately held companies] (Ongoing); Caranx: Consulting Fees (e.g., advisory boards) (Ongoing), Stock Options [in privately held companies] (Ongoing); Mass Medical Society: Editorial Fees (Ongoing); Medtronic: Consulting Fees (e.g., advisory boards) (Ongoing); MicroInterventional Devices: Consulting Fees (e.g., advisory boards) (Ongoing), Stock-privately held company (Ongoing)
Hasan A. Jilaihawi, MD
Professor
Cedars-Sinai Medical Center
Los Angeles, California, United States
Disclosure information not submitted.
Samir R. Kapadia, MD, FSCAI
Chairman, Cardiovascular Medicine
Cleveland Clinic
Cleveland, Ohio, United States
Disclosure information not submitted.
Puvi Seshiah, MD
Structural and Interventional Cardiologist
The Christ Hospital
Cincinnati, Ohio, United States
Disclosure(s): Edward Lifesciences: Consulting Fees (e.g., advisory boards) (Ongoing); Medtronic: Consulting Fees (e.g., advisory boards) (Ongoing); Shockwave: Consulting Fees (e.g., advisory boards) (Ongoing)
Alok Sharma, MD, FACC, FSCAI
Co-Director, Cardiac Cath lab and Structural Heart and Valve Program
Minneapolis VA Medical Center
Minneapolis, Minnesota, United States
Disclosure information not submitted.
Robert Stoler, MD
Director-Cardiac Catheterization Lab. Co-Chief of Cardiology
Baylor Heart & Vascular Hospital; Baylor University Medical Center
Dallas, Texas, United States
Disclosure information not submitted.
Jaffar M. Khan, MD, PhD
Director of Cardiovascular Innovation and Director of Interventional Electrosurgery
St Francis Hospital and Heart Center
Roslyn, New York, United States
Disclosure information not submitted.